Study Looks At Mitochondria In Genetic Model Of Parkinson's The fabled energy machines of the human cell, Mitochondria, have been for long regarded as ancient organisms which evolved from symbiotic organism into indispensable organels of human cells (animal and plant cells). The vestige of this process is the fact that Mitochondria posses their own DNA, … Continue reading Blarcamesine Has Been All About Mitochondrial Health For Years. Now, Parkinson’s Study Looks At Mitochondrial Health. $AVXL
Month: March 2022
Looking Under The Hood of PDD Phase 2 Blarcamsine Results. $AVXL $ANVS
One Picture Worth Few Drugs.... Section of AD/PD Conference 2022 Poster presented by Anavex Life Sciences. The full poster can be downloaded at https://79bcf7a1-8b8e-483b-b7cf-f5c5192a6d63.usrfiles.com/ugd/79bcf7_ff6b864593fb4418ab306474dd535d35.pdf Before I delve into the pretty picture here I shall reference the UPDRS content as it is undoubtfully of great value in understanding the implications of this section of the poster. … Continue reading Looking Under The Hood of PDD Phase 2 Blarcamsine Results. $AVXL $ANVS
Does 93% Of Patients Going Into Open Label Extension Bode Well For Blarcamesine Or Not?
Returning To My Old Friend... I have found outside of any paywall a very usefull paper as it looked at about six years of following probable Alzheimer's patients population of some 300 to 400 subjects. I derived many of my conclusions on Blarcamesine performance from this paper's content. The many assertion this paper was making … Continue reading Does 93% Of Patients Going Into Open Label Extension Bode Well For Blarcamesine Or Not?